|Articles|May 1, 1996

May 1996
Volume 2
Issue 5

The Relationship Between Borderline Personality Symptomatology and Healthcare Utilization Among Women in an HMO Setting

Author(s)Randy A. Sansone, MD, Michael W. Wiederman, PhD, Lori A. Sansone, MD

Download PDF: The Relationship Between Borderline Personality Symptomatology and Healthcare Utilization Among Women in an HMO Setting

Articles in this issue

over 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

over 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

over 30 years ago

Article

over 30 years ago

Article

The Professionalism of Pharmacy in a Managed Care Setting

over 30 years ago

Article

The Unique Application of Telemedicine to the Managed Healthcare System

over 30 years ago

Article

Management of the Menopausal Woman

over 30 years ago

Article

Using Administrative Data and a Diagnosis Clustering Program to Assess Healthcare Needs of African Americans

over 30 years ago

Article

Assessing the Real-Life Relationship Between Average Capillary Blood Glucose and Hemoglobin A1C: Is the Average Capillary Blood Glucose Value Clinically Useful?

over 30 years ago

Article

Any Willing IPA: Shaping the Market Through Legislation

over 30 years ago

Article

Health Care Credentialing and Qualifications Commission: An Alternative to "Any Willing Provider"?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

The Relationship Between Borderline Personality Symptomatology and Healthcare Utilization Among Women in an HMO Setting

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access